Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:1743172rdf:typepubmed:Citationlld:pubmed
pubmed-article:1743172lifeskim:mentionsumls-concept:C0013227lld:lifeskim
pubmed-article:1743172lifeskim:mentionsumls-concept:C0025663lld:lifeskim
pubmed-article:1743172lifeskim:mentionsumls-concept:C0003286lld:lifeskim
pubmed-article:1743172lifeskim:mentionsumls-concept:C2603343lld:lifeskim
pubmed-article:1743172lifeskim:mentionsumls-concept:C0201734lld:lifeskim
pubmed-article:1743172lifeskim:mentionsumls-concept:C0681758lld:lifeskim
pubmed-article:1743172lifeskim:mentionsumls-concept:C0003299lld:lifeskim
pubmed-article:1743172pubmed:dateCreated1992-1-10lld:pubmed
pubmed-article:1743172pubmed:abstractTextNew methods that will be useful in the study of the pharmacokinetics of both new and established antiepileptic drugs include stable-isotope tracer techniques for studies of absorption, elimination, and drug interactions; the microperfusion technique and the staggered stable-isotope administration technique for the study of distribution; and the correction of trough drug serum concentration values to mean serum concentration values. New pharmacokinetic methods for a study of drugs with new and unique properties include a double stable-isotope technique to deal with the unique pharmacokinetic properties of prodrugs and techniques for describing the biologic half-life of drugs that have a high affinity for active sites.lld:pubmed
pubmed-article:1743172pubmed:languageenglld:pubmed
pubmed-article:1743172pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:1743172pubmed:citationSubsetIMlld:pubmed
pubmed-article:1743172pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:1743172pubmed:statusMEDLINElld:pubmed
pubmed-article:1743172pubmed:issn0013-9580lld:pubmed
pubmed-article:1743172pubmed:authorpubmed-author:BrowneT RTRlld:pubmed
pubmed-article:1743172pubmed:authorpubmed-author:SzaboG KGKlld:pubmed
pubmed-article:1743172pubmed:issnTypePrintlld:pubmed
pubmed-article:1743172pubmed:volume32 Suppl 5lld:pubmed
pubmed-article:1743172pubmed:ownerNLMlld:pubmed
pubmed-article:1743172pubmed:authorsCompleteYlld:pubmed
pubmed-article:1743172pubmed:paginationS66-73lld:pubmed
pubmed-article:1743172pubmed:dateRevised2005-11-16lld:pubmed
pubmed-article:1743172pubmed:meshHeadingpubmed-meshheading:1743172-...lld:pubmed
pubmed-article:1743172pubmed:meshHeadingpubmed-meshheading:1743172-...lld:pubmed
pubmed-article:1743172pubmed:meshHeadingpubmed-meshheading:1743172-...lld:pubmed
pubmed-article:1743172pubmed:meshHeadingpubmed-meshheading:1743172-...lld:pubmed
pubmed-article:1743172pubmed:meshHeadingpubmed-meshheading:1743172-...lld:pubmed
pubmed-article:1743172pubmed:meshHeadingpubmed-meshheading:1743172-...lld:pubmed
pubmed-article:1743172pubmed:meshHeadingpubmed-meshheading:1743172-...lld:pubmed
pubmed-article:1743172pubmed:meshHeadingpubmed-meshheading:1743172-...lld:pubmed
pubmed-article:1743172pubmed:meshHeadingpubmed-meshheading:1743172-...lld:pubmed
pubmed-article:1743172pubmed:meshHeadingpubmed-meshheading:1743172-...lld:pubmed
pubmed-article:1743172pubmed:meshHeadingpubmed-meshheading:1743172-...lld:pubmed
pubmed-article:1743172pubmed:year1991lld:pubmed
pubmed-article:1743172pubmed:articleTitleNew pharmacokinetic methods for the study of antiepileptic medications of the 1990s.lld:pubmed
pubmed-article:1743172pubmed:affiliationDepartment of Neurology, Boston University School of Medicine, MA 02118.lld:pubmed
pubmed-article:1743172pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:1743172pubmed:publicationTypeReviewlld:pubmed